TreeFrog Therapeutics
Maxime Feyeux has a strong background in stem cell research and neurobiology. Currently serving as President, Chief Scientific Officer, and CEO/CSO of TreeFrog Therapeutics, Maxime aims to make cell therapies more accessible through innovative technology. Prior to this, Maxime worked as a Maturation Engineer at Aquitaine Science Transfert and held postdoctoral positions at Institut des Maladies Neurodégénératives and University of Geneva. Maxime's educational journey includes a PhD in Neurobiology and Neurosciences from Université d'Évry, a Master's degree in Cellular and Molecular Biology from École normale supérieure de Lyon, and a Baccalauréat in Science.